(S (NP-SBJ-28 (NP (JJ Age-related) (NNS decreases)) (PP (IN in) (NP (NP (NN IL-2) (NN production)) (PP (IN by) (NP (JJ human) (NN T) (NNS cells)))))) (VP (VBP are) (VP (VBN associated) (NP (-NONE- *-28)) (PP (IN with) (NP (NP (JJ impaired) (NN activation)) (PP (IN of) (NP (JJ nuclear) (JJ transcriptional) (NNS factors) (NP-COOD (NP (NN AP-1)) (CC and) (NP (NN NF-AT))))))))) (. .))
(S (SBAR (IN Although) (S (NP-SBJ-COOD (NP (JJ transcriptional) (NNS factors) (NN AP-1)) (CC and) (NP (NP (NP (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN NF-AT)) (-RRB- -RRB-)))) (VP (VBP are) (ADJP-PRD (JJ important)) (PP (IN for) (NP (NP (DT the) (JJ normal) (NN induction)) (PP (IN of) (NP (NN IL-2)))))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR (-NONE- *EXP*-30))) (VP (VBZ is) (ADJP-PRD (JJ unknown)) (SBAR-30 (IN if) (S (NP-SBJ-29 (NP (DT the) (JJ age-related) (NN decline)) (PP (IN in) (NP (NP (NN IL-2) (NN production)) (PP (IN by) (NP (VBN activated) (JJ human) (NN T) (NNS cells)))))) (VP (MD may) (VP (VB be) (VP (VBN associated) (NP (-NONE- *-29)) (PP (IN with) (NP (NP (NNS aberrancies)) (PP (IN in) (NP (JJ transcriptional) (JJ regulatory) (NNS proteins))))))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ current) (NNS studies))) (, ,) (NP-SBJ-31 (NP (NN IL-2) (NN production)) (PP (IN by) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (ADJP-COOD (ADJP (JJ elderly) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN mean)) (NP-PRD (CD 78) (NNS years))) (-RRB- -RRB-))) (CC and) (ADJP (JJ young) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN mean)) (NP-PRD (CD 37) (NNS years))) (-RRB- -RRB-)))) (NNS humans)))))) (VP (VBD was) (VP (VBN measured) (NP (-NONE- *-31)) (PP (IN in) (NP (NP (NNS cultures)) (VP (VBN stimulated) (NP (-NONE- *)) (PP (IN with) (NP-COOD (NP (NN PHA)) (, ,) (NP-COOD (NP (NN PHA)) (CC plus) (NP (NN PMA))) (, ,) (NP-COOD (NP (VBN crosslinked) (JJ anti-CD3) (NN mAB) (NN OKT3)) (CC plus) (NP (NN PMA))) (, ,) (CC or) (NP-COOD (NP (NN PMA)) (CC plus) (NP (NN ionomycin)))))))))) (. .))
(S-COOD (S (NP-SBJ-33 (NP (JJ Substantial) (NNS decreases)) (PP (IN of) (NP (NN IL-2) (NN production)))) (VP (VBD were) (VP (VBN observed) (NP (-NONE- *-33)) (PP (IN for) (NP (NP (NN cell) (NNS cultures)) (PP (IN from) (NP (QP (CD 7) (IN of) (CD 12)) (JJ elderly) (NNS individuals))))) (PP (IN in) (NN response) (TO to) (NP (DT the) (JJ different) (NNS stimuli)))))) (, ,) (IN whereas) (S (NP-SBJ (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN IL-2)) (VP (VBN produced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (VBN stimulated) (NN T) (NNS cells)) (PP (IN from) (NP (JJ other) (JJ elderly) (NNS individuals))))))))) (VP (VBD were) (ADJP-PRD (JJ equivalent) (PP (TO to) (NP (NP (DT those)) (VP (VBN observed) (NP (-NONE- *)) (PP (IN for) (NP (NP (VBN stimulated) (NN T) (NNS cells)) (PP (IN of) (NP (JJ young) (NNS subjects))))))))))) (. .))
(S (NP-SBJ (NP (NNS Analyses)) (PP (IN of) (NP (JJ nuclear) (NNS extracts))) (PP (IN by) (NP (JJ electrophoretic) (NN DNA) (NN mobility) (NN shift) (NNS assays)))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-35 (NP (VBN decreased) (NN IL-2) (NN production)) (PP (IN by) (NP (NP (VBN stimulated) (NN T) (NNS cells)) (PP (IN of) (NP (JJ elderly) (NNS individuals)))))) (VP (VBD was) (ADVP (RB closely)) (VP (VBN associated) (NP (-NONE- *-35)) (PP (IN with) (NP (NP (NNS impairments)) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP-COOD (CC both) (NP (NN AP-1)) (CC and) (NP (NN NF-AT))))))))))))) (. .))
(S (PP (IN By) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ elderly) (NNS subjects)) (PP (IN with) (NP (NP (JJ normal) (NNS levels)) (PP (IN of) (NP (NN IL-2) (NN production)))))))) (VP (VBD exhibited) (NP (NP (JJ normal) (NN activation)) (PP (IN of) (NP-COOD (NP (NN AP-1)) (CC and) (NP (NN NF-AT)))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (NN competition) (NNS experiments)) (VP (VBG analyzing) (NP (NP (DT the) (JJ normal) (NNS components)) (PP (IN of) (NP (NN NF-AT)))))))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ age-related) (NNS reductions)) (PP (IN in) (NP (JJ stimulus-dependent) (NN NF-AT) (NNS complexes)))) (VP (VBD corresponded) (PP (TO to) (NP (NP (DT the) (ADJP (JJ slow) (VBG migrating)) (NNS complexes)) (SBAR (WHNP-36 (WDT that)) (S (NP-SBJ-37 (-NONE- *T*-36)) (VP (VBD were) (VP (VBN composed) (NP (-NONE- *-37)) (PP (IN of) (NP (NN (c-Jun c-Fos)) (NN AP-1))))))))))))) (. .))
(S (S (NP-SBJ-38 (NP (DT The) (ADJP-COOD (ADJP (JJ resting)) (CC and) (ADJP (JJ stimulated))) (NNS levels)) (PP (IN of) (NP (NN NF) (NN kappa) (NN B)))) (VP (VBD were) (VP (VBN reduced) (NP (-NONE- *-38)) (PP (IN in) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (JJ certain) (JJ elderly) (NNS individuals))))))) (: ;)) (S (ADVP (RB however)) (, ,) (NP-SBJ (NP (NNS alterations)) (PP (IN of) (NP (NN NF) (NN kappa) (NN B)))) (VP (VBD did) (RB not) (VP (VB correlate) (PP (IN with) (NP (NP (NNS changes)) (PP (IN in) (NP (NN IL-2) (NN expression))))))) (. .)))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ (DT these) (NNS results)) (VP-COOD (VP (VBP show) (SBAR (IN that) (S (NP-SBJ-39 (NP (JJ age-related) (NNS impairments)) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP-COOD (NP (NN AP-1)) (CC and) (NP (NN NF-AT))))))) (VP (VBP are) (ADVP (RB closely)) (VP (VBN associated) (NP (-NONE- *-39)) (PP (IN with) (NP (NP (VBN decreased) (NN expression)) (PP (IN of) (NP (NN IL-2)))))))))) (CC and) (VP (ADVP (RB further)) (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (NNS aberrancies)) (PP (IN in) (NP (DT the) (NN signaling) (NNS pathways))) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (ADJP (RB transcriptionally) (JJ active)) (NN (c-Jun c-Fos)) (NN AP-1))))))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (JJ impaired) (NN activation)) (PP (IN of) (NP (NN NF-AT))))))))))) (. .))
